Welcome to the e-CCO Library!

P353: Ulcerative Colitis in the IBSEN III study: Frequent use of biologics and low colectomy rates first year of disease.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Strande, V.(1,2,3)*;Lund, C.(3,4);Småstuen, M.C.(4,5);Bengtson, M.B.(6);Cetinkaya, R.B.(7);Detlie, T.E.(3,8);Frigstad, S.O.(9);Medhus, A.W.(3,4);Henriksen, M.(10);Holten, K.I.A.(3,10);Hovde, Ø.(3,11);Huppertz-Hauss, G.(12);Johansen, I.(13,14);Olsen, B.C.(3,12);Pallenschat, J.(15);Perminow, G.(16);Ricanek, P.(2,8);Torp, R.(17);Tønnessen, T.(18);Vatn, S.(8);Aabrekk, T.B.(3,6);Opheim, R.(4,14);Høivik, M.L.(3,4);Kristensen, V.A.(1,4);
Created: Friday, 14 July 2023, 11:05 AM
P354 Objectively measured time spent sitting, standing upright, and stepping is associated with disease severity and faecal calprotectin in patients with ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Raman1, J. Vallance2, K. Lyden3, S. Alana4, C. Ohland5, K. McCoy5, S. Kaur1, R. Panaccione1, R. Reimer6, L. Taylor1

Created: Thursday, 30 January 2020, 10:12 AM
P354: A prospective randomised study: 2 mg/kg/d of azathioprine is an appropriate dosage for Chinese patients with Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Y. Zhang*, J. Xia, Q. Cao

Created: Friday, 22 February 2019, 9:49 AM
P354: Application of the clinical decision support tool to predict treatment outcomes in Crohn's Disease patients treated with vedolizumab subcutaneous formulation
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Dulai, P.(1)*;Lindner, D.(2);Agboton, C.(3);Alric, H.(4);Bamias, G.(5);Peyrin-Biroulet, L.(6);
Created: Friday, 14 July 2023, 11:05 AM
P354: Early treatment versus active surveillance after ileocolic resection in Crohn’s disease: a retrospective cohort study.
Year: 2021
Source: ECCO'21 Virtual
Authors: Haenen, S.(1);Sabino, J.(1);Bislenghi, G.(2);D'Hoore, A.(2);Ferrante, M.(1);Vermeire, S.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P354: Immunological response to vaccination against SARS-COV-2 infection in Inflammatory Bowel Disease patients under immunosuppressive therapy: should we prioritize an additional booster injection?
Year: 2022
Source: ECCO'22
Authors: Macedo Silva, V.(1,2,3);Lima Capela, T.(1,2,3);Freitas, M.(1,2,3);Cúrdia Gonçalves, T.(1,2,3);Boal Carvalho, P.(1,2,3);Dias de Castro, F.(1,2,3);Moreira, M.J.(1,2,3);Cotter, J.(1,2,3);
Created: Friday, 11 February 2022, 3:52 PM
P354: Perceived Quality of Care is associated to quality of life, work productivity and gender but not disease phenotype: a prospective study in a high-volume IBD centre
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Gonczi*1, Z. Kurti1, C. Verdon2, J. Reinglas2, R. Kohen2, I. Morin2, K. Chavez2, T. Bessissow2, W. Afif2, G. Wild2, E. Seidman2, A. Bitton2, P. Lakatos2

Created: Friday, 22 February 2019, 9:41 AM
P354: Refinement and confirmation of psychometric properties of the Inflammatory Bowel Disease Distress Scale (IBD-DS): A new tool to measure disease-specific distress
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Dibley1,2*, W. Czuber-Dochan3, S. Woodward3, T. Wade3, P. Bassett4, J. Sturt3, C. Norton3, The IBD-DS Patient and Public Involvement Team3

Created: Thursday, 21 February 2019, 9:14 AM
P354: The effect of value based health care delivery for inflammatory bowel diseases on outcomes of patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zand A., Aredas E., Duran N., DiNicola C., Lacey P., Arenas A., Hommes D.W.

Created: Wednesday, 20 February 2019, 10:36 AM
P355 Acceptability of treatment regimen in inflammatory bowel disease: Results from a prospective nationwide study (ACCEPT2)
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Buisson1, M. Fumery2, M. Serrero3, L. Orsat1, S. Nancey4, P. Rivière5, R. Altwegg6, L. Peyrin-Biroulet7, M. Nachury8, X. Hébuterne9, C. Gilletta10, M. Flamant11, S. Viennot12, G. Bouguen13, A. Amiot14, S. Mathieu15, L. Vuitton16, L. Plastaras17, A. Bourreille18, L. Caillo19, F. Goutorbe20, M. Fumery21, G. Pineton de Chambrun6, A. Attar22, X. Roblin23, B. Pereira24, B. Pariente8

Created: Thursday, 30 January 2020, 10:12 AM
P355: A structured care pathway improves quality of care for acute severe ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Neary B., Doherty G., Rafter N., Gibson D.

Created: Wednesday, 20 February 2019, 10:36 AM
P355: Diagnostic accuracy and usability of home calprotectin testing
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Thomas*1, M. Clarke1, V. Cairns1, J. Goodhand1, T. Ahmad1, N. Kennedy1

Created: Friday, 22 February 2019, 9:41 AM
P355: Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

D. Seah*1, 2, M. Choy1, 2, 3, A. Gorelik4, F. Macrae5, M. Sparrow6, W.R. Connell3, G. Moore7, D. Van Langenberg8, P. De Cruz1, 2

Created: Friday, 22 February 2019, 9:49 AM
P355: Exceeding treatment expectations in Crohn's disease: transmural healing and a new definition of deep remission
Year: 2022
Source: ECCO'22
Authors: Castiglione, F.(1);Imperatore, N.(1);Testa, A.(1);de Sire, R.(1);Nardone, O.M.(1);Ricciolino, S.(1);Di Luna, I.(1);Patturelli, M.(1);Villani, G.D.(1);Olmo, O.(1);Rispo, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
P355: Motility in small bowel strictures in Crohn's Disease measured with cine-MRI
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Beek, K.(1)*;de Jonge, C.S.(1);van Rijn, K.(1);de Voogd, F.A.E.(2);Buskens , C.J.(3);D'Haens , G.(2);Gecse, K.B.(2);Stoker, J.(1);
Created: Friday, 14 July 2023, 11:05 AM
P355: Preferences and satisfaction of IBD patients in whom the adalimumab regimen was changed from 40 mg weekly to 80 mg every other week: the ADASCAL study
Year: 2021
Source: ECCO'21 Virtual
Authors: Taxonera Samso, C.(1);Martínez-Montiel, P.(2);Barreiro-De-Acosta, M.(3);Vera, I.(4);Lorente, R.(5);Vega, P.(6);Diz-Lois, M.T.(7);Fuentes Coronel, A.M.(8);Pérez Calle, J.L.(9);Casis, B.(2);Ferreiro, R.(3);Calvo, M.(4);Olivares, D.(1);Alba, C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P355: Prevalence, clinical characteristics and outcomes of CMV colitis in a cohort of 95 patients with ulcerative colitis: A 7-year retrospective analysis
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Carvão1*, J. Alves2, V. Magno Pereira1, C. Sousa Andrade1, H. Morna1, G. Andrade2, L. Jasmins1

Created: Thursday, 21 February 2019, 9:14 AM
P356 Infectious events in patients with inflammatory bowel disease: The impact of immunomodulators and tumour necrosis factor antagonist therapy
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. Andersson, P. Karling

Created: Thursday, 30 January 2020, 10:12 AM
P356: A comparison of innovative strategies to promote engagement with an IBD patient portal
Year: 2021
Source: ECCO'21 Virtual
Authors: Carlson, S.(1);McCartney, S.(1);Harrow, P.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P356: CRAB Score, An Indian Insight into in hospital and long-term Colectomy following Acute Severe Ulcerative Colitis (ASUC)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Varghese, J.(1)*;
Created: Friday, 14 July 2023, 11:05 AM